BNET Industries
Last Fiscal Year Sales:$52.5M
- Private
- US
Dow Jones Description
The egg arrived and then came Embrex. Founded in 1985 and headquartered in Durham, NC, Embrex Inc. develops biological products for poultry, domestically as well as internationally. The company markets the Inovoject system, which can process up to 70,000 eggs per hour, therefore abolishing the need for manual injection of vaccines. The company also makes poultry vaccines, such as Newplex and Bursaplex, in addition to research and development services. It has annual revenue of over $52 million and has about 300 employees. In April 2006, USDA granted product and manufacturing facility licenses to produce and sell Inovocox(TM), in ovo coccidiosis vaccine.
President & CEO
Randall L. MarcusonNumber of Employees 309
Contact Information
1040 Swabia Ct
PO Box 13989
Durham, North Carolina 27703-8481
1 919 941 5185
Peer Companies
NAICS Code Biological Product (except Diagnostic) Manufacturing: 325414
Recent Events
-
Reportlinker Adds Veterinary Vaccines - A World Market Analysis
News & Analysis
Filter by
embrex inc. and randall - All News and Analysis
Embrex Announces First Quarter 2006 Financial Results Release and Conference Call
RESEARCH TRIANGLE PARK, N.C. -- EmbrexR, Inc., The In Ovo CompanyR, (Nasdaq:EMBX) announced Embrex management intends to file its First Quarter 2006 Form 10-Q and issue its financial press release on Monday, May 8, 2006. Embrex's management, led by President and CEO Randall L. Marcuson, will further discuss these financial...
Embrex Announces Third Quarter 2005 Financial Results Release and Conference Call
RESEARCH TRIANGLE PARK, N.C. -- EmbrexR, Inc., The In Ovo CompanyR, (NASDAQ:EMBX) announced Embrex management intends to file its Third Quarter 2005 Form 10-Q and issue its financial press release on Tuesday, November 1, 2005. Embrex's management, led by President and CEO Randall L. Marcuson, will further discuss these financial...
Embrex Announces Second Quarter 2005 Financial Results Release and Conference Call
RESEARCH TRIANGLE PARK, N.C. -- EmbrexR, Inc., The In Ovo CompanyR, (NASDAQ: EMBX) announced Embrex management intends to file its Second Quarter 2005 Form 10-Q and issue its financial press release on Tuesday, August 2, 2005. Embrex's management, led by President and CEO Randall L. Marcuson, will further discuss these...
CORRECTED: Embrex Announces First Quarter 2005 Financial Results Release and Conference Call
RESEARCH TRIANGLE PARK, N.C. -- EmbrexR, Inc., The In Ovo CompanyR, (NASDAQ:EMBX) announced Embrex management intends to file its First Quarter 2005 Form 10-Q and issue its financial press release on Tuesday, May 3, 2005. Embrex's management, led by President and CEO Randall L. Marcuson, will further discuss these financial...
Embrex Announces Fourth Quarter, Year-End 2004 Financial Results Release and Conference Call
RESEARCH TRIANGLE PARK, N.C. -- EmbrexR, Inc., The In Ovo CompanyR, (Nasdaq:EMBX) announced Embrex management intends to file its Year-End and Fourth Quarter 2004 Form 10-K and issue its financial press release on Tuesday, March 15, 2005. Embrex's management, led by President and CEO Randall L. Marcuson, will further discuss...
Embrex Announces Third Quarter 2004 Financial Results Release and Conference Call
RESEARCH TRIANGLE PARK, N.C. -- Embrex, Inc., The In Ovo CompanyR, (Nasdaq:EMBX) announced Embrex management intends to file its Third Quarter 2004 Form 10-Q and issue its financial press release on Tuesday, November 2, 2004. Embrex's management, led by President and CEO Randall L. Marcuson, will further discuss these financial...
Embrex Announces Second Quarter 2004 Financial Results Release and Conference Call
RESEARCH TRIANGLE PARK, N.C. -- Embrex, Inc., The In Ovo CompanySM, (Nasdaq:EMBX) announced Embrex management intends to file its Second Quarter 2004 Form 10-Q and issue its financial press release on Tuesday, August 3, 2004. Embrex's management, led by President and CEO Randall L. Marcuson, will further discuss these financial...
Embrex Announces Third Quarter 2002 Financial Conference Call And Earnings Release Date
Business Editors RESEARCH TRIANGLE PARK, N.C.--BUSINESS WIRE--Oct. 10, 2002 Embrex, Inc., The In Ovo CompanySM, (Nasdaq: EMBX) will release third-quarter 2002 financial results on Tuesday, October 29, 2002 before the Nasdaq market opens. Embrex's management, led by President and CEO Randall L. Marcuson, will then discuss third-quarter and...
Embrex Announces Second Quarter 2002 Financial Conference Call And Earnings Release Date
Business Editors Embrex, Inc., The In Ovo CompanySM, (Nasdaq: EMBX) will release Second Quarter 2002 financial results on Tuesday, July 30, 2002 before the Nasdaq market opens. Embrex's management led by President and CEO Randall Marcuson will then discuss second quarter and year-to-date results in a conference call at...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Randall L. Marcuson | President & CEO |
| Brian Hrudka | Vice President, Marketing & Latin America |
| Catherine Ricks | Vice President, Res & Development |
| David M. Baines | Vice President, Sales, Global |
| Don T. Seaquist | Vice President, Finance, Administration |
| Ellen Moore | Vice President, Investor Relations & Communications |
| Joseph P. O'Dowd | Vice President, Product Development |
| Robin Shyr | Vice President |
| David Shapiro | Senior Director, Global Veterinary Services |
| Phoebe Johnson | Manager, Marketing Services |
| Gerald Roach | General Counsel |
| John E KIein |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Harold V Smith | Chairman |
| C. Daniel Blackshear | Board of Directors |
| C. Daniel Seaquist | Board of Directors |
| David L. Castaldi | Board of Directors |
| Ganesh M. Kishore | Board of Directors |
| John E. Klein | Board of Directors |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | President & CEO | Current |
| Embrex Inc. | President & CEO | Current |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Vice President, Marketing & Latin America | Current |
| Novartis AG | Brand Manager | Former |
| The University of Western Ontario | B.S. degree in biochemistry and an MBA | Former |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Vice President, Res & Development | Current |
| Immunobiosciences Inc. | Vice President of Research and Development at Embrex | Current |
| Immunobiosciences Inc. | Board of Directors | Current |
| North Carolina State University | Adjunct Professor | Former |
| Michigan State University | Ph.D. In Nutritional Biochemistry | Former |
| King's College | Ph.D. In Nutritional Biochemistry | Former |
| University of London | M.S. in plant physiology | Former |
| King's College | B.Sc. In Botany | Former |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Vice President, Sales, Global | Current |
| University of London | Ph.D. degree in entomology | Former |
| Reading University | B.Sc. degree in zoology | Former |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Vice President, Finance, Administration | Current |
| Embrex Inc. | Vice President, Finance, Admin | Current |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Vice President, Investor Relations & Communications | Current |
| Tufts University | bachelor's degree in political science | Former |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Vice President, Product Development | Current |
| California State University | B.A. in Asian Studies | Former |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Vice President | Current |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Senior Director, Global Veterinary Services | Current |
| Embrex Inc. | Senior Director, Global Veterinary Services | Former |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Manager, Marketing Services | Current |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | General Counsel | Current |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Current | |
| Washington University | Executive Vice Chancellor of Administration | Former |
| Bunge Limited | Former | |
| Sullivan & Cromwell LLP | Former |
| Organization | Position | Status |
|---|---|---|
| Lasys, Inc | President, CEO | Current |
| Sterling Drug | Current | |
| Abbott Laboratories | Current | |
| Embrex Inc. | Chairman | Current |
| Eco-Gen, Ltd | Chairman | Current |
| Lasys, Inc | Chairman | Current |
| Ensys | Chairman | Current |
| University of California, Los Angeles | B.S. Degree | Former |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Board of Directors | Current |
| The University of Georgia | M.S. degree in Food Science and Management | Former |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Board of Directors | Current |
| Biolex, Inc. | Board of Directors | Current |
| Baxter International Inc. | Former | |
| Genzyme Corporation | Former | |
| University of Notre Dame | B.A. degree in business | Former |
| Organization | Position | Status |
|---|---|---|
| Mlscf | CEO | Current |
| Burrill & Company | Managing Director | Current |
| Embrex Inc. | Board of Directors | Current |
| Monsanto Company | Chief Biotechnologist | Former |
| DuPont Qualicon | Vice President, Tech, Chief BioTech Officer | Former |
| E.I. du Pont de Nemours & Company | Vice President, Technology, Agriculture & Nutrition | Former |
| Monsanto Company | Distinguished Science Fellow | Former |
| Indian Institute of Science | PhD In Biochemistry | Former |
| University of Mysore | degrees in biochemistry, physics and chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Embrex Inc. | Board of Directors | Current |
Executive News
-
Joseph O'Dowd Joins SteriFx Inc. Global sales, marketing and R&D professional to bolster pathogen control leader.
-
Joseph O'Dowd Joins SteriFx Inc.
-
Joseph O'Dowd Joins SteriFx Inc.
Industry Transcripts by Seeking Alpha
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Why J&J's Stelara Launch Should Target Dermatologists First 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes

